EliseAI, an AI startup focused on automating administrative tasks in housing and healthcare, raised $350 million at a $4 billion valuation, doubling its worth since last year. The funding round was co-led by Andreessen Horowitz and Bessemer Ventures. EliseAI's software supports 1 in 6 U.S. apartments and recently surpassed $200 million in annual recurring revenue. The company also launched an AI assistant named Apollo to enhance its platform's efficiency across property management and healthcare operations, targeting two major expense areas for American households.
EliseAI's recent $350 million funding and $4 billion valuation provide context for technology sector activity on Pluang. For readers following this sector, here is Pluang's market snapshot as of Sep 30, 2026 04:01 WIB: Among 150 priced US tech stocks, 69 rose and 81 fell. Marvell Technology Inc (MRVL) gained 4.57% to USD 263.42 with 62% of orders selling and a typical hold time of 41 days. In contrast, Five9 Inc (FIVN) and Workiva Inc (WK) declined by 4.47% and 4.30% respectively, with typical hold times of 71 and 21 days.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
